# US 2012/0237558 A1 · Method of treating an osteochondral defect

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0237558 A1
- Document ID: US20120237558A1
- Status: Published application
- Kind: A1
- Application number: 13/327,286
- Filed: 2011-12-15
- Published: 2012-09-20
- Earliest claimed: 2003-12-11
- Assignees: Zimmer, Inc.; Isto Techologies, Inc.
- Inventors: Neil Kizer; Robert Spiro; Jian Yao; Cheryl Renee Blanchard
- Web page: https://patentgrep.com/patent/US20120237558A1

## CPC

- A61L 27/3683: {subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment}
- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61L 27/3612: {Cartilage, synovial fluid}
- A61L 27/3654: {Cartilage, e.g. meniscus}
- A61L 27/3817: {Cartilage-forming cells, e.g. pre-chondrocytes}
- A61L 27/3852: {Cartilage, e.g. meniscus}
- A61P 19/00: Drugs for skeletal disorders
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 19/04: for non-specific disorders of the connective tissue
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- C12N 5/0655: {Chondrocytes; Cartilage}
- A61F 2/28: Bones
- A61F 2002/30764: {Cartilage harvest sites}
- A61F 2002/30766: {Scaffolds for cartilage ingrowth and regeneration}
- A61F 2310/00293: containing a phosphorus-containing compound, e.g. apatite
- A61F 2310/00365: Proteins; Polypeptides; Degradation products thereof
- A61F 2310/00377: Fibrin
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- C12N 2533/56: Fibrin; Thrombin
- C12N 2533/80: Hyaluronan
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention is directed to compositions having at least one neocartilage particle, juvenile cartilage particle or a combination thereof and a matrix, and methods and devices that include the compositions.

## Claims

### Claim 1

A method of treating an ostechondral defect, comprising:
disposing an osteo-conductive matrix in the defect;
implanting cadaveric, allogenic human juvenile cartilage particles including viable chondrocytes into the defect; and
depositing a chondro-conductive matrix into the defect.

### Claim 2 (depends on 1)

The method of claim 1, wherein the osteo-conductive matrix is disposed in the defect prior to implanting the cartilage particles.

### Claim 3 (depends on 1, 2)

The method of claim 1 or 2, wherein the cartilage particles are implanted and the chondro-conductive matrix is deposited simultaneously.

### Claim 4 (depends on 3)

The method of claim 3, wherein the cartilage particles and the chondro-conductive matrix comprise a single construct.

### Claim 5 (depends on 4)

The method of claim 4, wherein a preformed single construct is produced by delivering the cartilage particles and the chondro-conductive matrix to a mold.

### Claim 6 (depends on 4)

The method of claim 4, wherein the preformed single construct is attached to the osteo-conductive matrix or cartilage or bone adjacent the defect by gluing.

### Claim 7 (depends on 3, 9)

The method of claim 3 or 9, wherein the cartilage particles are implanted and the chondro-conductive matrix is deposited through a cannulated device.

### Claim 8 (depends on 7)

The method of claim 7, wherein the cartilage particles and the chondro-conductive matrix are mixed during deposition.

### Claim 9 (depends on 1)

The method of claim 1, wherein the cartilage particles are implanted and the chondro-conductive matrix is deposited sequentially.

### Claim 10 (depends on 9)

The method of claim 9, wherein chondro-conductive matrix is deposited after cartilage particles are implanted into the defect.

### Claim 11 (depends on 1)

The method of claim 1, further comprising applying a retainer to the defect.

### Claim 12 (depends on 11)

The method of claim 11, wherein the retainer comprises a glue.

### Claim 13 (depends on 1)

The method of claim 1, wherein the osteo-conductive matrix is disposed up to the tide mark adjacent the osteochondral defect.

### Claim 14 (depends on 1)

The method of claim 1, wherein the osteo-conductive matrix is selected from the group consisting of a porous solid, semisolid, paste or gel.

### Claim 15 (depends on 14)

The method of claim 14, wherein the osteo-conductive matrix comprises a porous solid.

### Claim 16 (depends on 15)

The method of claim 15, wherein the porous solid comprises an interconnected structure.

### Claim 17 (depends on 16)

The method of claim 16, wherein the porous solid comprises cancellous bone.

### Claim 18 (depends on 1)

The method of claim 1, wherein the osteo-conductive matrix is selected from the group consisting of bone or a calcium phosphate containing composition.

### Claim 19 (depends on 18)

The method of claim 18, wherein the bone is demineralized.

### Claim 20 (depends on 1)

The method of claim 1, further comprising removing the cartilage particles from a container including a biocompatible storage solution.

### Claim 22 (depends on 1)

The method of claim 1, wherein the cartilage particles have a dimension from about one to about three millimeters.

### Claim 23 (depends on 1, 2, 9, 11, 15, 20)

The method of any one of claim 1, 2, 9, 11, 15 or 20, wherein the cartilage particles range in size from about 1 to about 27 mm3.

### Claim 24 (depends on 1)

The method of claim 1, wherein the cartilage particles comprise articular cartilage.

### Claim 25 (depends on 1)

The method of claim 1, wherein the chondro-conductive matrix is selected from the group consisting of plasma-based adhesives or sealants, and protein-based adhesives or sealants, natural adhesives or sealants and any combination thereof.

### Claim 26 (depends on 25)

The method of claim 25, wherein the chondro-conductive matrix is fibrin.

### Claim 27 (depends on 1, 2, 9, 11, 15, 20)

The method of claim 1, 2, 9, 11, 15 or 20, wherein the cartilage particles are from cadaveric juvenile donors less than fifteen years of age.

### Claim 28 (depends on 27)

The method of claim 27, wherein the cartilage particles are from cadaveric juvenile donors less than two years of age.

### Claim 29 (depends on 27)

The method of claim 27, wherein the cartilage particles are from cadaveric juvenile donors from about 20 weeks to about 13 years of age.
